Seres Therapeutics, Inc. (MCRB) NASDAQ
8.28
-0.39(-4.50%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.28
-0.39(-4.50%)
Currency In USD
| Market Cap | 131.82M |
| Enterprise Value | 169.02M |
| P/E Ratio | 12.88 |
| PEG Ratio | 2 |
| Price/Sales Ratio | 94.94 |
| Price/Book Ratio | 1.66 |
| Enterprise/Revenue | 142.09 |
| Enterprise/EBITDA | 16.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 7.22 |
| Operating Margin | -119.1 |
| Return On Assets | 0.04 |
| Return On Equity | 0.13 |
| Revenue | 789,000 |
| Revenue/Share | 0.09 |
| Gross Profit | -3.34M |
| EBITDA | -89.84M |
| Net Income | 5.7M |
| Diluted EPS | 0.64 |
| Total Cash | 45.77M |
| Total Cash/Share | 5.17 |
| Total Debt | 82.97M |
| Total Debt/Equity | 1.88 |
| Current Ratio | 2.56 |
| Book Value Per Share | 4.99 |
| 52-Week Change | -41.94 |
| 52-Week High | 29.98 |
| 52-Week Low | 6.53 |
| Moving Average 50 Days | 11.81 |
| Moving Average 200 Days | 14.69 |
| Average Volume | 67,811 |
| Shares Outstanding | 9.05M |
| % Held by Institutions | 27.88 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | April 22, 2025 |